Done sou Salè H1B

Akèy › Anplwayè › Regeneron Pharmaceuticals, Inc. › Sr. Scientist

Sr. Scientist nan Regeneron Pharmaceuticals, Inc.: Salè H-1B

23 aplikasyon kondisyon travay pou tit travay Sr. Scientist nan Regeneron Pharmaceuticals, Inc.. Salè baz medyàn ofri $142,799; mwatye mitan $139,992–$145,609.

Demann (LCA)23
Salè medyan ofri$142,799
Mwatye salè yo$139,992–$145,609
10yèm–90yèm pousantaj$136,592–$148,835

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20232$132,500
FY20241$140,000
FY20253$138,442
FY202617$144,733

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$145,271
Nivo II		Tarrytown, NYJan 23, 2026Jul 21, 2026Certifye
$149,510
Nivo II		Tarrytown, NYJan 23, 2026Jul 21, 2026Certifye
$145,947
Nivo II		Tarrytown, NYJan 23, 2026Jul 22, 2026Certifye
$142,233
Nivo II		Tarrytown, NYJan 23, 2026Jul 22, 2026Certifye
$149,429
Nivo II		Tarrytown, NYJan 23, 2026Jul 22, 2026Certifye
$142,380
Nivo II		Tarrytown, NYJan 23, 2026Jul 22, 2026Certifye
$140,253
Nivo II		Tarrytown, NYJan 23, 2026Jul 19, 2026Certifye
$148,900
Nivo II		Tarrytown, NYJan 22, 2026Jul 23, 2026Certifye
$144,273
Nivo II		Tarrytown, NYJan 20, 2026Jul 16, 2026Certifye
$148,577
Nivo III		Tarrytown, NYJan 20, 2026Jul 16, 2026Certifye
$140,000
Nivo III		Tarrytown, NYJan 20, 2026Jul 16, 2026Certifye
$139,985
Nivo II		Tarrytown, NYJan 15, 2026Jul 12, 2026Certifye
$144,733
Nivo III		Tarrytown, NYJan 12, 2026Jul 10, 2026Certifye
$147,783
Nivo III		Tarrytown, NYJan 12, 2026Jun 18, 2026Certifye
$143,863
Nivo II		Tarrytown, NYJan 12, 2026Jun 18, 2026Certifye
$142,799
Nivo II		Tarrytown, NYJan 12, 2026Jul 9, 2026Certifye
$145,000
Nivo II		Tarrytown, NYNov 4, 2025Nov 10, 2025Certifye
$136,129
Nivo III		Tarrytown, NYMar 7, 2025Sep 6, 2025Certifye
$139,595
Nivo II		Tarrytown, NYSep 24, 2024Oct 1, 2024Certifye
$138,442
Nivo II		Tarrytown, NYSep 24, 2024Mar 4, 2025Certifye
$140,000
Nivo II		Tarrytown, NYMay 10, 2024Oct 1, 2024Certifye
$130,000
Nivo II		Tarrytown, NYAug 31, 2023Oct 1, 2023Certifye
$135,000
Nivo III		Tarrytown, NYJun 1, 2023Jun 19, 2023Certifye

Sr. Scientist nan tout anplwayè yo →

Lòt travay nan Regeneron Pharmaceuticals, Inc.

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).